with suspected clinical symptoms and APC-sr ( 6 5), although the odds ratio for VTE was not significant with D-dimer ( 6 5). Conclusion: These data suggest that an APC sensitivity test can be a possible surrogate diagnostic marker of suspected VTE during pregnancy and puerperium. Copyright © 2011 S. Karger AG, Basel 
potential (ETP; time integral of thrombin generated in clotting plasma) shows a progressive increase with the duration of a normal uncomplicated pregnancy, although little is known with regard to whether the increased thrombin generation is associated with thrombotic disorders in pregnancy and puerperium [5] .
Protein C is a principle component in the anticoagulant pathway and the elevated risk of VTE in the persons with congenital activated protein C (APC) resistance suggests an important role in the onset of thrombotic disorders [6] . APC exerts its anticoagulant function by proteolytic cleavage of procoagulant protein factor Va and factor VIIIa with protein S as a cofactor in this reaction [7] .
Several studies on the changes in sensitivity to APC by activated partial thromboplastin time (aPTT)-based assay for the detection of APC resistance indicate a decreased response to APC during normal pregnancy [8, 9] . Decreased functional sensitivity to APC during pregnancy was demonstrated using an ETP-based assay in a group of arbitrarily selected healthy Japanese females without a background of congenital or acquired thrombophilia [10] . That study also showed that the functional sensitivity to APC of 4 females at the onset of VTE was significantly reduced in comparison to the sensitivity to APC of the females without VTE during puerperium. Furthermore, the sensitivity to APC, as shown by an ETP-based assay, has been observed to markedly decrease in a patient just prior to the onset of superior sagittal sinus thrombosis during puerperium without any significant changes in D-dimer [11] .
Although a previous study has proposed the normal range of D-dimer in pregnancy for diagnosis of VTE [12] , the progressive increase and individual variation of Ddimer during the period have led to difficulties in ruling out VTE [13] . At present, D-dimer is a marker with poor value for excluding VTE during pregnancy and immediate puerperium [14] , likely because the fibrinolytic response to venous occlusion and fibrin in the placental circulation during pregnancy and in the intrauterine cavity during puerperium is enhanced [15] .
These observations suggest that a significant reduction of sensitivity to APC may be a diagnostic marker of the latent or suspected VTE during pregnancy and puerperium. Furthermore, a recent advance in the ETP-based APC sensitivity assay with computer-assisted calibrated thrombography [16] now allows the real-time evaluation of larger samples.
This study compared the ETP-based sensitivity to APC in uncomplicated normal pregnant females with those in patients with VTE at onset to evaluate the clinical significance of the reduced sensitivity to APC using a real-time ETP-based assay with assisted calibrated thrombography and to examine whether the reduced sensitivity to APC can be a surrogate diagnostic marker of suspected VTE.
Methods

Reagents
Microtiter (96-well) plates were purchased from Corning Inc. (New York, N.Y., USA). Fluorogenic synthetic substrate Z-GlyGly-Arg-AMC was obtained from Bachem AG (Bubendorf, Switzerland). Tissue factor (TF; Innovin ) was purchased from DADE-Behring (Marburg, Germany). Purified APC was a generous donation of the Chemo-Sero-Therapeutic Research Institute (Kumamoto, Japan). All other reagents were of the highest analytical grade.
Blood Specimens
Blood was obtained from healthy Japanese non-pregnant females, healthy Japanese pregnant females and patients with VTE at the onset before anticoagulation in pregnancy or puerperium. Those pregnant females were chosen arbitrarily from pregnant females who delivered at Hamamatsu University Hospital between December 2007 and November 2008. The blood was collected from pregnant females in pregnancy and puerperium. The pregnant participants had a normal vaginal delivery or a cesarean delivery. The indications for cesarean section were breech presentation, previous cesarean delivery and uterine myoma. All cesarean sections were scheduled electively before the onset of labor. There were no obstetrical complications, i.e. no pregnancy-induced hypertension (systolic blood pressure 1 140 mm Hg or diastolic blood pressure ! 90 mm Hg), preeclampsia, gestational or insulin-dependent diabetes mellitus, preterm delivery, placenta previa, pathological fetal heart rate monitoring pattern, abnormal hemorrhage during the puerperium. Participants had neither a past nor a family history of thrombosis, and there was no antiphospholipid syndrome. VTE was diagnosed and confirmed at the Department of Radiology by venography, Doppler blood flow scanning or CT scanning.
Approval for the study was granted by the Hamamatsu University Review Board in 2007. Informed consent was obtained from all participants prior to blood collection.
Preparation of Platelet-Free Plasma
Citrate platelet-rich plasma was prepared from blood (9/vol) collected in sodium citrate (1 vol, final conc. 0.38%, 13 m M ). Platelet-free plasma was obtained by centrifugation of platelet-rich plasma for 15 min at 175 g and filtration through a Durapore TM filter with a pore size of 0.22 m (Millipore Corp., Bedford, Mass., USA). Platelet-free plasma was immediately frozen and stored in small aliquots at -20 ° C until analysis. The obtained samples were assayed within 48 h.
ETP-Based APC Sensitivity Assay
Thrombin generation in the plasma was essentially determined by the ETP-based method of Hemker and Bèguin [17] and Duchemin et al. [18] , with minor modifications. by the thrombin formed in plasma was followed in Fluoroscan Acent reader (Thermo Electron Corp., Vantaa, Finland) every minute for 30 min at 37 ° C. Thrombin generation curves and the ETP were calculated using the Thrombinoscope TM software program (Synapse BV, Maastricht, The Netherlands). Thrombin generation was expressed in relative fluorescent units and converted to thrombin concentrations (n M ) using a reference curve prepared by purified thrombin. All thrombin generation curves were determined in duplicate unless otherwise stated.
The effect of APC on the ETP ratio in sample plasma was measured, and the APC-sensitivity ratio (sr) was defined as the ratio of thrombin generation by ␣ 2 -macroglobulin-thrombin complex determined in the presence and absence of APC divided by the ratio determined in the normal pooled plasma. An elevated APCsr thus indicated a reduced sensitivity to APC. In each experiment, the APC concentration was such as to reduce the ETP of the normal pooled plasma to 10% of the ETP determined in the absence of APC. 
Measurement of D-Dimer
Results
Backgrounds in Arbitrarily Selected Pregnant Females at Delivery, Normal Non-Pregnant Females and Patients with VTE in Pregnancy or Puerperium
The backgrounds of the 200 healthy Japanese nonpregnant females and the 111 arbitrarily selected pregnant females including cesarean delivery and vaginal delivery, and the 7 patients with VTE at onset are shown in table 1 . The characteristics in pregnant females are shown for females who had a cesarean delivery (n = 58) and females who had a normal vaginal delivery (n = 53). Maternal BMI was significantly higher in the cesarean group (26.0 8 4.8) than in the normal delivery group (23.5 8 
Changes in ETP and APC-sr in Arbitrarily Selected Pregnant Females, Comparing with Non-Pregnant Females and Patients with VTE in Pregnancy or Puerperium
The mean ETP (n M ! min) was elevated during pregnancy and puerperium significantly ( fig. 1 ) and the sensitivity to APC at 32-35 weeks' gestation (2.78 8 0.92) and at 1-6 days after delivery (3.37 8 1.03) was reduced in comparison to the sensitivity to APC in normal nonpregnant females (p ! 0.05, paired t test; fig. 2 ).
In contrast, the mean ETP in patients with VTE at onset was not significantly elevated in comparison to that in normal pregnant females ( fig. 1 ) , although the sensitivity to APC in patients with VTE (5.95 8 1.53) was reduced in comparison to that in the late pregnancy period and puerperium (p ! 0.05; fig. 2 ). Interestingly, there was no significant difference in the ETP and sensitivity to APC between the cesarean delivery group (1,832 8 340 nm ! min, 3.20 8 1.05) and normal vaginal delivery group (1,841 8 434 nm ! min, 3.55 8 0.99) in puerperium ( fig. 1 , 2 ). 
Odds Ratios for VTE in Pregnant Females with the APC-sr or with D-Dimer Level
The odds ratios for VTE in pregnant females with a cut-off of APC-sr 6 5 or with a cut-off of D-dimer level 6 5 g/ml are shown in table 3 . The cut-off of APC-sr 6 5 or of D-dimer level 6 5 g/ml was determined at the maximum of odds ratios, respectively. The odds ratio for VTE was 31.9 in pregnant females with APC-sr 6 5 with statistical significance although the odds ratio for VTE was not significant in pregnant females with a D-dimer level 6 5 g/ml.
Discussion
This study shows that the functional sensitivity to APC based on a real-time ETP-based assay is reduced in patients with VTE at onset in comparison to that in un- complicated pregnant females in pregnancy and puerperium. The odds ratio for VTE was 31.9 with statistical significance in pregnant females with suspected clinical symptoms and APC-sr ( 6 5), although the odds ratio for VTE was not significant in pregnant females with D-dimer ( 6 5). These data demonstrate that APC sensitivity testing can be a surrogate marker for suspected VTE and important in determining the need for further invasive diagnostic examination. In the present study, the functional sensitivity to APC was initially shown by a real-time ETP-based assay to be significantly reduced on the first day after delivery in comparison to the sensitivity to APC in normal nonpregnant females and during late gestational period in consecutive blood samples from 111 arbitrarily selected pregnant females without a background of congenital or acquired thrombophilia. ETP was increased progressively during pregnancy and puerperium; however, ETP in patients with VTE at onset was not elevated in comparison to that in normal pregnant females, although the sensitivity to APC in patients with VTE was reduced in comparison to that in late gestational period and puerperium significantly. These data were consistent with previous observations [10] . Similar studies on the sensitivity to APC during pregnancy in a Western Europe population included heterozygous carriers of the factor V Leiden mutation [6] . The prevalence in the European population of APC resistance is between 3 and 7% [19] . In contrast, the data presented in the current study show changes in the sensitivity to APC in pregnant Japanese females without this genetic form of APC resistance because no factor V Leiden mutation has yet been detected in the Japanese [20] [21] [22] . Therefore, the reduced functional sensitivity to APC in Japanese pregnant females indicates phenotypic resistance without FV Leiden.
At present, there are two global tests used for the detection of APC resistance with aPTT-and ETP-based methods. The major determinant of the aPTT-based test is FVIII level, while the ETP-based test is influenced most by free protein S and free TFPI levels [23] . Both the Comparison between ETP and APC-sr in patients with VTE and arbitrarily selected pregnant females in late pregnancy or puerperium. ETP and APCsr were compared in patients (n = 7) with VTE at onset and arbitrarily selected pregnant females (n = 111) in late pregnancy or puerperium. There were no significant relationships between ETP and APC-sr (r = 0.18, p ! 0.05) by Spearman's correlation coefficient. o = Late gestational period: from 32 to 35 weeks' gestation in normal pregnant females; _ = 1st day of puerperium in normal pregnant females; I = patients with DVT/PTE at onset in pregnancy or puerperium.
aPTT-and the ETP-based APC sensitivity test have demonstrated that a reduced sensitivity to APC in patients without FV Leiden also increases the risk of venous thrombosis [24, 25] , although a study showed that the ETP-based APC sensitivity test was not a risk marker for VTE during pregnancy [26] . However, as they pointed out, their study design was retrospective and they compared normalized APC-sr in non-pregnant females with a past history of VTE in pregnancy and puerperium with normalized APC-sr in healthy females. This does not provide information about the association between temporal changes in reduced sensitivity to APC with ETPbased assay and thrombotic events because temporal functional changes in sensitivity to APC are important during pregnancy and puerperium. At this point, it still remains unclear whether the reduction of sensitivity to APC in patients with VTE is the cause or the result of VTE in the current study. The data presented here showed a significant reduction in the sensitivity to APC in patients with VTE at onset in comparison to that in healthy uncomplicated late pregnancy and puerperium alone. In this retrospective study, it is difficult to conclude that the temporal functional reduction to sensitivity to APC is associated with increased risk of VTE in pregnancy and puerperium. However, no significant elevation of ETP in patients with VTE at onset suggests that reduced sensitivity to APC has an important role in the development to VTE in pregnancy and puerperium. Interestingly, ETP and sensitivity to APC showed no significant difference between the cesarean delivery group and normal vaginal delivery group in puerperium. This indicates that reduced sensitivity is not related to the risk of VTE in cesarean delivery but that of VTE in pregnancy and puerperium. The reduced sensitivity to APC is independent of the delivery mode.
In conclusion, these observations may indicate that a significant reduction of the sensitivity to APC with a realtime ETP-based APC sensitivity test can be a simple alternative diagnostic testing in patients with suspected VTE as one of the pretest probability assessments since D-dimer measurement is not diagnostic during the highrisk period of immediate puerperium [27, 28] . However, because of the limited number of 7 pathological patients in this presentation, it is difficult to establish real changes in the diagnostic capacity. The discussion should be cautious with these results that lead to the conclusion. Further prospective clinical studies in a larger cohort study are needed to confirm that a significant reduction in the sensitivity to APC is diagnostic or predictive of an increased risk of VTE at the present time. An animal model of thrombosis would be helpful in understanding the relationship between VTE and pathological changes in the sensitivity to APC during pregnancy and early puerperium.
